Skip to main content
Erschienen in: Abdominal Radiology 9/2018

09.02.2018 | Pictorial essay

Hepatobiliary phase liver MR imaging findings after Oxaliplatin-based chemotherapy in cancer patients

verfasst von: Emre Ünal, Ali Devrim Karaosmanoğlu, Mustafa Nasuh Ozmen, Deniz Akata, Musturay Karcaaltincaba

Erschienen in: Abdominal Radiology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe Gd-EOB-DTPA-enhanced liver MR imaging findings in colon and rectal cancer patients who received Oxaliplatin.

Conclusion

Spectrum of hepatobiliary phase imaging findings include diffuse heterogeneous dysfunction, macronodular and micronodular FNH-like lesions, and coexistence of periportal increased liver function with FNH-like lesions. Differentiation of these benign lesions from metastasis is crucial to avoid biopsy in patients with colorectal cancers and may allow better understanding of sinusoidal obstruction syndrome pathophysiology and regenerative response of liver.
Literatur
1.
Zurück zum Zitat Aloia T, Sebagh M, Plasse M, et al. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983–4990CrossRefPubMed Aloia T, Sebagh M, Plasse M, et al. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983–4990CrossRefPubMed
2.
Zurück zum Zitat Morine Y, Shimada M, Utsunomiya T (2014) Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis. Hepatol Res 44:59–69CrossRefPubMed Morine Y, Shimada M, Utsunomiya T (2014) Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis. Hepatol Res 44:59–69CrossRefPubMed
3.
Zurück zum Zitat Rubbia-Brandt L, Lauwers GY, Wang H, et al. (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439CrossRefPubMed Rubbia-Brandt L, Lauwers GY, Wang H, et al. (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439CrossRefPubMed
4.
Zurück zum Zitat Han NY, Park BJ, Sung DJ, et al. (2014) Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical–pathologic correlation. Radiology 271:416–425CrossRefPubMed Han NY, Park BJ, Sung DJ, et al. (2014) Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical–pathologic correlation. Radiology 271:416–425CrossRefPubMed
5.
Zurück zum Zitat Shin NY, Kim MJ, Lim JS, et al. (2012) Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 22:864–871CrossRefPubMed Shin NY, Kim MJ, Lim JS, et al. (2012) Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 22:864–871CrossRefPubMed
6.
Zurück zum Zitat Narita M, Oussoultzoglou E, Chenard MP, et al. (2011) Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization. Surg Today 41:7–17CrossRefPubMed Narita M, Oussoultzoglou E, Chenard MP, et al. (2011) Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization. Surg Today 41:7–17CrossRefPubMed
7.
Zurück zum Zitat Mehta NN, Ravikumar R, Coldham CA, et al. (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782–786CrossRefPubMed Mehta NN, Ravikumar R, Coldham CA, et al. (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782–786CrossRefPubMed
8.
Zurück zum Zitat Nakano H, Oussoultzoglou E, Rosso E, et al. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118–124CrossRefPubMed Nakano H, Oussoultzoglou E, Rosso E, et al. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118–124CrossRefPubMed
9.
Zurück zum Zitat Arakawa Y, Shimada M, Utsunomya T, et al. (2013) Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res 43:685–689CrossRefPubMed Arakawa Y, Shimada M, Utsunomya T, et al. (2013) Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res 43:685–689CrossRefPubMed
10.
Zurück zum Zitat Choi JH, Won YW, Kim HS, et al. (2016) Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver. Oncol Lett 11:2861–2864CrossRefPubMedPubMedCentral Choi JH, Won YW, Kim HS, et al. (2016) Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver. Oncol Lett 11:2861–2864CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Overman MJ, Maru DM, Charnsangavej C, et al. (2010) Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28:2549–2555CrossRefPubMed Overman MJ, Maru DM, Charnsangavej C, et al. (2010) Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28:2549–2555CrossRefPubMed
12.
Zurück zum Zitat Ward J, Guthrie JA, Sheridan MB, et al. (2008) Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 26:4304–4310CrossRefPubMed Ward J, Guthrie JA, Sheridan MB, et al. (2008) Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 26:4304–4310CrossRefPubMed
13.
Zurück zum Zitat Han NY, Park BJ, Yang KS, et al. (2017) Hepatic parenchymal heterogeneity as a marker for oxaliplatin-induced sinusoidal obstruction syndrome: correlation with treatment response of colorectal cancer liver metastases. AJR Am J Roentgenol 209:1–7CrossRef Han NY, Park BJ, Yang KS, et al. (2017) Hepatic parenchymal heterogeneity as a marker for oxaliplatin-induced sinusoidal obstruction syndrome: correlation with treatment response of colorectal cancer liver metastases. AJR Am J Roentgenol 209:1–7CrossRef
14.
Zurück zum Zitat Donadon M, Di Tommaso L, Roncalli M, Torzilli G (2013) Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy. World J Hepatol 5:340–344CrossRefPubMedPubMedCentral Donadon M, Di Tommaso L, Roncalli M, Torzilli G (2013) Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy. World J Hepatol 5:340–344CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed
16.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A, et al. (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508CrossRefPubMed
17.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A, et al. (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027CrossRefPubMed
18.
Zurück zum Zitat Dioguardi Burgio M, Ronot M, Salvaggio G, Vilgrain V, Brancatelli G (2016) Imaging of hepatic focal nodular hyperplasia: pictorial review and diagnostic strategy. Semin Ultrasound CT MR 37:511–524CrossRefPubMed Dioguardi Burgio M, Ronot M, Salvaggio G, Vilgrain V, Brancatelli G (2016) Imaging of hepatic focal nodular hyperplasia: pictorial review and diagnostic strategy. Semin Ultrasound CT MR 37:511–524CrossRefPubMed
19.
Zurück zum Zitat Benz-Bohm G, Hero B, Gossmann A, et al. (2010) Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary? Eur J Radiol 74:e1–e5CrossRefPubMed Benz-Bohm G, Hero B, Gossmann A, et al. (2010) Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary? Eur J Radiol 74:e1–e5CrossRefPubMed
20.
Zurück zum Zitat Bouyn CI, Leclere J, Raimondo G, et al. (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113CrossRefPubMed Bouyn CI, Leclere J, Raimondo G, et al. (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113CrossRefPubMed
21.
Zurück zum Zitat Marin D, Galluzzo A, Plessier A, et al. (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082CrossRefPubMed Marin D, Galluzzo A, Plessier A, et al. (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082CrossRefPubMed
22.
Zurück zum Zitat Smith EA, Salisbury S, Martin R, Towbin AJ (2012) Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. AJR Am J Roentgenol 199:186–191CrossRefPubMed Smith EA, Salisbury S, Martin R, Towbin AJ (2012) Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. AJR Am J Roentgenol 199:186–191CrossRefPubMed
23.
Zurück zum Zitat Yoo SY, Kim JH, Eo H, et al. (2013) Dynamic MRI findings and clinical features of benign hypervascular hepatic nodules in childhood-cancer survivors. AJR Am J Roentgenol 201:178–184CrossRefPubMed Yoo SY, Kim JH, Eo H, et al. (2013) Dynamic MRI findings and clinical features of benign hypervascular hepatic nodules in childhood-cancer survivors. AJR Am J Roentgenol 201:178–184CrossRefPubMed
24.
Zurück zum Zitat Cha DI, Yoo SY, Kim JH, Jeon TY, Eo H (2014) Clinical and imaging features of focal nodular hyperplasia in children. AJR Am J Roentgenol 202:960–965CrossRefPubMed Cha DI, Yoo SY, Kim JH, Jeon TY, Eo H (2014) Clinical and imaging features of focal nodular hyperplasia in children. AJR Am J Roentgenol 202:960–965CrossRefPubMed
25.
Zurück zum Zitat Joyner BL Jr, Levin TL, Goyal RK, Newman B (2005) Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol 35:1234–1239CrossRefPubMed Joyner BL Jr, Levin TL, Goyal RK, Newman B (2005) Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol 35:1234–1239CrossRefPubMed
26.
Zurück zum Zitat Kitao A, Zen Y, Matsui O, et al. (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed Kitao A, Zen Y, Matsui O, et al. (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed
27.
Zurück zum Zitat Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797CrossRefPubMed Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797CrossRefPubMed
28.
Zurück zum Zitat Fujiwara H, Sekine S, Onaya H, et al. (2011) Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological–pathological correlation. Jpn J Radiol 29:739–743CrossRefPubMed Fujiwara H, Sekine S, Onaya H, et al. (2011) Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological–pathological correlation. Jpn J Radiol 29:739–743CrossRefPubMed
29.
Zurück zum Zitat Vander Borght S, Libbrecht L, Blokzijl H, et al. (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207:471–482CrossRefPubMed Vander Borght S, Libbrecht L, Blokzijl H, et al. (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207:471–482CrossRefPubMed
30.
Zurück zum Zitat Pawlik TM, Olino K, Gleisner AL, et al. (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868CrossRefPubMed Pawlik TM, Olino K, Gleisner AL, et al. (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868CrossRefPubMed
31.
Zurück zum Zitat Vauthey JN, Pawlik TM, Ribero D, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed
32.
Zurück zum Zitat Hamer OW, Aguirre DA, Casola G, et al. (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26:1637–1653CrossRefPubMed Hamer OW, Aguirre DA, Casola G, et al. (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26:1637–1653CrossRefPubMed
33.
Zurück zum Zitat Jang JK, Jang HJ, Kim JS, Kim TK (2017) Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol (NY) 42:1667–1678CrossRef Jang JK, Jang HJ, Kim JS, Kim TK (2017) Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol (NY) 42:1667–1678CrossRef
34.
Zurück zum Zitat Unal E, Karaosmanoglu AD, Akata D, Ozmen MN, Karcaaltincaba M (2016) Invisible fat on CT: making it visible by MRI. Diagn Interv Radiol 22:133–140CrossRefPubMed Unal E, Karaosmanoglu AD, Akata D, Ozmen MN, Karcaaltincaba M (2016) Invisible fat on CT: making it visible by MRI. Diagn Interv Radiol 22:133–140CrossRefPubMed
35.
Zurück zum Zitat Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M (2016) Magnetic resonance imaging of liver metastasis. Semin Ultrasound CT MR 37:533–548CrossRefPubMed Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M (2016) Magnetic resonance imaging of liver metastasis. Semin Ultrasound CT MR 37:533–548CrossRefPubMed
36.
Zurück zum Zitat Unal E, Akata D, Karcaaltincaba M (2016) Liver function assessment by magnetic resonance imaging. Semin Ultrasound CT MR 37:549–560CrossRefPubMed Unal E, Akata D, Karcaaltincaba M (2016) Liver function assessment by magnetic resonance imaging. Semin Ultrasound CT MR 37:549–560CrossRefPubMed
Metadaten
Titel
Hepatobiliary phase liver MR imaging findings after Oxaliplatin-based chemotherapy in cancer patients
verfasst von
Emre Ünal
Ali Devrim Karaosmanoğlu
Mustafa Nasuh Ozmen
Deniz Akata
Musturay Karcaaltincaba
Publikationsdatum
09.02.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 9/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1482-7

Weitere Artikel der Ausgabe 9/2018

Abdominal Radiology 9/2018 Zur Ausgabe

Classics in Abdominal Radiology

The “perinephric cobwebs” sign

Classics in Abdominal Radiology

The onion skin sign of appendiceal mucocele

Classics in Abdominal Radiology

Cecal arrowhead sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.